BMI1 and non-small cell lung carcinoma: Additional studies are needed to gain mechanistic insight into how Bmi1 is involved in generation of lung CSCs and how its expression levels in whole blood might be utilized as a potential longitudinal biomarker of disease spread and treatment response in NSCLC and wider.